Unlike its healthy counterpart, the mutated version of the huntingtin protein that drives Huntington’s disease may keep nerve cells…
Articles by Margarida Maia, PhD
Vico Therapeutics’ investigational therapy VO659 was found to lower levels of the disease-causing mutant huntingtin (HTT) protein — known…
Researchers in the U.S. have created the first brain-like organoids, or mini-brains, that incorporate a working blood-brain barrier (BBB), which…
uniQure expects to begin planned discussions with the U.S. Food and Drug Administration (FDA) in the coming months to outline…
Ayana Bio was awarded $300,000 from the National Institutes of Health (NIH) to sample saffron — the world’s most…
The U.S. Food and Drug Administration (FDA) has approved Neurocrine Biosciences’ oral granules formulation of Ingrezza (valbenazine) — called…
A type of brain nerve cells called layer 5a pyramidal neurons — especially those projecting into the striatum, a brain…
Scientists at the University of California, Irvine (UCI) have mapped onto a genetic database nearly a million tandem repeat (TR)…
Cariprazine, an oral medication approved for schizophrenia, may ease some motor symptoms people with Huntington’s disease experience across different…
Prilenia Therapeutics plans to submit a marketing authorization application (MAA) by mid-year asking for approval in the European Union of…